Evidence map›Paper›PMID 42012883›Full record

ArticleJCI insight2026

Th2 skewing in patients with disseminated coccidioidomycosis.

Timothy J Thauland, Smriti S Nagarajan, Alexis V Stephens, Samantha L Jensen, Anviksha Srivastava, Miguel A Moreno Lastre, Terrie S Ahn, Chantana Bun, Michael T Trump, Royce H Johnson and 4 more

Abstract read
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Timothy J ThaulandDepartment of Pediatrics, Division of Immunology, Allergy, and Rheumatology, and.
Smriti S NagarajanDepartment of Pediatrics, Division of Immunology, Allergy, and Rheumatology, and.
Alexis V StephensDepartment of Human Genetics, UCLA, Los Angeles, California, USA.
Samantha L JensenDepartment of Human Genetics, UCLA, Los Angeles, California, USA.
Anviksha SrivastavaDepartment of Pediatrics, Division of Immunology, Allergy, and Rheumatology, and.
Miguel A Moreno LastreDepartment of Pediatrics, Division of Immunology, Allergy, and Rheumatology, and.
Terrie S AhnDepartment of Pediatrics, Division of Immunology, Allergy, and Rheumatology, and.
Chantana BunDepartment of Pediatrics, Division of Immunology, Allergy, and Rheumatology, and.
Michael T TrumpDepartment of Pediatrics, Division of Immunology, Allergy, and Rheumatology, and.
Royce H JohnsonDepartment of Medicine, Division of Infectious Diseases, Kern Medical Center, Bakersfield, California, USA.
George R ThompsonDepartment of Medicine, Division of Infectious Diseases, and.
Maria I Garcia-LloretDepartment of Pediatrics, Division of Immunology, Allergy, and Rheumatology, and.
Valerie A ArboledaDepartment of Human Genetics, UCLA, Los Angeles, California, USA.
Manish J ButteDepartment of Pediatrics, Division of Immunology, Allergy, and Rheumatology, and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUNDDisseminated coccidioidomycosis (DCM) is an often fatal and otherwise intractable condition requiring lifelong antifungal treatment. We have previously shown that a deranged polarization of CD4+ T cells toward a Th2 phenotype can exist in the context of DCM. Here, we studied a large population to determine the frequency of abnormal Th2 skewing of CD4+ T cells in patients with coccidioidomycosis and to identify underlying genetic mechanisms supporting this phenotype.METHODSWe collected PBMCs from 204 patients with coccidioidomycosis, including 96 patients with disseminated disease. We measured immune phenotypes and cytokine production by CD4+ T cells from patients and healthy controls, and comparisons between groups were made based on disease severity and demographics. Whole-genome sequencing was conducted on 180 individuals who also had cytokine profiling.RESULTSWe found that approximately 25% of patients with DCM had a CD4+ T cell compartment that was abnormally skewed toward a Th2 phenotype, and Th2 skewing was highly correlated with male sex. Coculture of T cells with the IL-4R/IL-13R-blocking antibody dupilumab reduced Th2 skewing. Sequencing revealed rare variants in genes involved in the IL-12/IFN-γ axis in several Th2-skewed patients, and we validated one such variant in IFNGR1 as hypomorphic.CONCLUSIONPatients with DCM, especially males, should be screened for Th2 skewing of CD4+ T cells. Patients with Th2 skewing should be additionally screened for genetic defects in the IL-12/IFN-γ axis. Our findings give a mechanistic rationale for blockade of IL-4R in Th2-skewed patients with refractory coccidioidomycosis.FUNDINGNational Institute of Allergy and Infectious Diseases/NIH grants R21 AI149654 and U19 AI166059 and University of California Office of the President grant VFR-19-633386.

Indexed as

CoccidioidomycosisTh2 CellsAdultAgedCD4-Positive T-LymphocytesCytokinesFemaleHumansInterferon-gammaInterleukin-12MaleMiddle AgedWhole Genome SequencingCytokinesInterferon-gammaInterleukin-12Adaptive immunityFungal infectionsImmunologyImmunotherapyInfectious disease

Identifiers

PMID42012883
PMCPMC13232725

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.